Form 4 for TMO Thermo Fisher Scientific
Accepted 2026-09-01 16:10:46 ET · period of report 2026-08-28 · accession 0000097745-26-000162 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-09-01 16:10 | 2026-08-28 | TMO | Pettiti Gianluca | Pres, COO | F - Tax | $622.18 | -1,035 | 23.6K | -4% | -$643.8K |
| DMT | 2026-09-01 16:10 | 2026-08-31 | TMO | Pettiti Gianluca | Pres, COO | S - Sale+OE | $614.38 | -4,133 | 23.2K | -15% | -$2.54M |
| DT | 2026-09-01 16:10 | 2026-08-31 | TMO | Pettiti Gianluca | Pres, COO | M - OptEx | $309.63 | +3,733 | 26.9K | +16% | +$1.16M |
| DT | 2026-09-01 16:10 | 2026-08-31 | TMO | Pettiti Gianluca | Pres, COO | M - OptEx | $0.00 | -3,733 | 7,467 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-28 | F | D | 212.26 | $622.18 | 24,438.58 | D | — | — | |
| 2 | Common | Common Stock | 2026-08-28 | F | D | 303.64 | $622.18 | 24,134.94 | D | — | — | |
| 3 | Common | Common Stock | 2026-08-28 | F | D | 249.00 | $622.18 | 23,885.93 | D | — | — | |
| 4 | Common | Common Stock | 2026-08-28 | F | D | 269.79 | $622.18 | 23,616.14 | D | — | — | |
| 5 | Common | Common Stock | 2026-08-31 | S | D | 400 | $614.38 | 23,216.14 | D | — | — | (F1) The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 2, 2026. |
| 6 | Common | Common Stock | 2026-08-31 | M | A | 3,733 | $309.63 | 26,949.14 | D | — | — | |
| 7 | Common | Common Stock | 2026-08-31 | S | D | 3,733 | $614.38 | 23,216.14 | D | — | — | (F1) The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 2, 2026. |
| 8 | Derivative | Stock Option (Right to Buy) | 2026-08-31 | M | D | 3,733 | $0.00 | 7,467 | D | $309.63 · — to 2027-02-25 | 3,733 Common Stock | (F2) The option vested in four equal installments on February 25, 2021, 2022, 2023 and 2024. |